Viemed Healthcare (VMD) Free Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.83% |
| Dec 31, 2025 | 620.59% |
| Sep 30, 2025 | -174.86% |
| Jun 30, 2025 | 1,646.56% |
| Mar 31, 2025 | -104.92% |
| Dec 31, 2024 | 24.14% |
| Sep 30, 2024 | 27.63% |
| Jun 30, 2024 | 888.91% |
| Mar 31, 2024 | -109.44% |
| Dec 31, 2023 | -18.72% |
| Sep 30, 2023 | 66.99% |
| Jun 30, 2023 | 68.15% |
| Mar 31, 2023 | -76.62% |
| Dec 31, 2022 | 369.35% |
| Sep 30, 2022 | -287.47% |
| Jun 30, 2022 | -30.10% |
| Mar 31, 2022 | -66.66% |
| Dec 31, 2021 | 803.36% |
| Sep 30, 2021 | -247.80% |
| Jun 30, 2021 | -118.67% |
| Mar 31, 2021 | 386.65% |
| Dec 31, 2020 | 212.95% |
| Sep 30, 2020 | -103.29% |
| Jun 30, 2020 | 807.72% |
| Mar 31, 2020 | -120.09% |
| Dec 31, 2019 | 470.15% |
| Sep 30, 2019 | -191.44% |
| Jun 30, 2019 | 717.38% |
| Mar 31, 2019 | -88.53% |
| Dec 31, 2018 | 55.50% |